Aim: Circulating thyroid hormone concentrations are influenced by nonthyroidal disease and changes in nutritional status. We studied thyroid hormones as possible indicators of nutrition in adolescent girls with eating disorders. Method: Blood samples for analyses of thyroid hormones were obtained at 360 assessments of 298 patients and biweekly during 42 treatment periods in 36 patients. Results: At assessment, when most of the girls were on a weight losing course, serum triiodothyronine (T3) concentrations were low. Great weight loss and rapid rate of weight loss were the most important predictors of low T3 concentrations. Serum free thyroxine concentrations were in the lower normal range. In premenarcheal girls, weight loss was the most important predictor of free thyroxine but this relationship was weaker in postmenarcheal girls. Serum TSH concentrations were within the normal range and only weakly related to weight changes. During treatment, T3 increased in parallel with weight but was also influenced by the short-term weight trend. Conclusion: Serum T3 concentration is an indicator of nutritional status in adolescent girls with eating disorders. It is sensitive to short-term weight changes and could be used to monitor progress throughout nutritional rehabilitation.

1.
Jung RT, Shetty PS, James WPT: The effect of refeeding after semistarvation on catecholamine and thyroid metabolism. Int J Obes 1980;4:95–100.
2.
Hugues J-N, Burger AG, Pekary AR, Hershman JM: Rapid adaptations of serum thyrotropin, triiodothyronine and reverse triiodothyronine levels to short-term starvation and refeeding. Acta Endocrinol 1984;105:194–199.
3.
Jahreis G, Kauf E, Fröhner G, Schmidt HE: Influence of extensive exercise on insulin-like growth factor I, thyroid hormones and steroid hormones in female gymnasts. Growth Regul 1991;1:95–99.
4.
Loucks AB, Thuma JR: Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab 2003;88:297–311.
5.
Roza AM, Tuitt D, Shizgal HM: Transferrin – a poor measure of nutritional status. J Parenter Enter Nutr 1984;8:523–528.
6.
Unterman TG, Vazquez RM, Slas AJ, Martyn PA, Phillips LS: Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment. Am J Med 1984;78:228–234.
7.
Smith G, Robinson PH, Fleck A: Serum albumin distribution in early treated anorexia nervosa. Nutrition 1996;12:677–684.
8.
Danforth E Jr, Burger AG: The impact of nutrition on thyroid hormone physiology and action. Annu Rev Nutr 1989;9:201–227.
9.
Loucks AB, Heath EM: Induction of a low-T3 syndrome in exercising women occurs at a threshold of energy availability. Am J Physiol 1994;266:R817–R823.
10.
Støving RK, Hangaard J, Hagen C: Update on endocrine disturbances in anorexia nervosa. J Pediatr Endocrinol Metab 2001;14:459–480.
11.
De Zwaan M, Aslam Z, Mitchell JE: Research on energy expenditure in individuals with eating disorders: a review. Int J Eating Disord 2002;31:361–369.
12.
Moshang T Jr, Parks JS, Baker L, Vaidya V, Utiger RD, Bongiovanni AM, Snyder PJ: Low serum triiodothyronine in patients with anorexia nervosa. J Clin Endocrinol Metab 1975;40:470–473.
13.
Miyai K, Yamamoto T, Azukizawa M, Ishibashi K, Kumahara Y: Serum thyroid hormones and thyrotropin in anorexia nervosa. J Clin Endocrinol Metab 1975;40:334–338.
14.
Croxson MS, Ibbertsson HK: Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa. J Clin Endocrinol Metab 1977;44:167–174.
15.
Leslie RDG, Isaacs AJ, Gomez J, Raggatt PR, Bayliss R: Hypothalamo-pituitary-thyroid function in anorexia nervosa: influence of weight gain. BMJ 1978;2:526–528.
16.
DeRosa G, Della Casa S, Corsello SM, Ruffilli MP, DeRosa E, Pasargiklian E: Thyroid function in altered nutritional states. Exp Clin Endocrinol 1983;82:173–177.
17.
Tamai H, Mori K, Matsubayashi S, Kiyohara K, Nakagawa T, Okimura MC, Walter RM, Kumagi LF, Nagataki S: Hypothalamic-pituitary-thyroidal dysfunctions in anorexia nervosa. Psychother Psychosom 1986;46:127–131.
18.
Bannai C, Kuzuya N, Koide Y, Fujita T, Itakura M, Kawai K, Yamashita K: Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 1988;35:455–462.
19.
Kiyohara K, Tamai H, Takaichi Y, Nakagawa T, Kumagai LF: Decreased thyroidal secretion in patients with anorexia nervosa: influence of weight recovery. Am J Clin Nutr 1989;50:767–772.
20.
Onur S, Haas V, Bosy-Westphal A, Hauer M, Nutzinger D, Klein H, Müller J: L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol 2005;152:179–184.
21.
American Psychiatric Association: Diagnostic and Statistic Manual for Mental Disorders, ed 4 (DSM-IV). Washington, American Psychiatric Association, 1994, pp 539–550.
22.
Lindgren G, Strandell A, Cole T, Healy M, Tanner J: Swedish population standards for height, weight and body mass index attained at 6 to 16 years (girls) or 19 years (boys). Acta Paediatr 1995;84:1019–1028.
23.
McIver B, Gorman CA: Euthyroid sick syndrome: an overview. Thyroid 1997;7:125–132.
24.
Kelly G: Peripheral metabolism of thyroid hormones: a review. Alternative Med Rev 2000;5:306–333.
25.
Bianco AC, Kim BW: Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 2006;116:2571–2579.
26.
Swenne I, Stridsberg M, Thurfjell B, Rosling A: Insulin-like growth factor I (IGF-I) as an indicator of nutritional status at assessment and during treatment of adolescent girls with eating disorders. Acta Paediatr 2007;96:1203–1208.
27.
Andersen S, Pedersen KM, Bruun NH, Laurberg P: Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002;87:1068–1072.
28.
Haggarty Jr JJ, Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ Jr: Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatr 1993;150:508–510.
29.
Larisch R, Kley K, Nikolaus S, Sitte W, Franz M, Hautzel H, Tress W, Müller H-W: Depression and anxiety in different thyroid function states. Horm Metab Res 2004;36:650–653.
30.
Bono G, Fancellu R, Blandini F, Santoro G, Mauri M: Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 2004;110:59–66.
31.
Fountoulakis KN, Kantartzis S, Siamoulii M, Panagiotidis P, Kaprinis S, Iacovides A, Kapprinis G: Peripheral thyroid function in depression. World J Biol Psychiatr 2006;7:131–137.
32.
Joffe R, Marriot M: Thyroid hormone levels and recurrence of major depression. Am J Psychiatr 2000;157:1689–1691.
33.
Gitlin M, Altshuler LL, Frye MA, Suri R, Huynh EL, Fairbanks L, Bauer M, Korenman S: Peripheral thyroid hormones and response to serotonin uptake inhibitors. J Psychiatr Neurosci 2004;29:383–386.
34.
Abulseoud O, Sane N, Cozzolino A, Kiriakos L, Mehra V, Gitlin M, Masseling S, Whybrow P, Altshuler LL, Mintz J, Frye MA: Free T4 index and clinical outcome in patients with depression. J Affect Disord 2007;100:271–277.
35.
DeBattista C, Lembke A: Update on augmentation of antidepressant response in resistant depression. Curr Psychiatr Reports 2005;7:435–440.
36.
Lifschytz T, Segman R, Shalom G, Lerer B, Gur E, Golzer T, Newman ME: Basic mechanisms for augmentation of antidepressant effects with thyroid hormones. Curr Drug Targets 2006;7:203–210.
37.
Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G: A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatr 2006;163:1519–1530.
38.
Abraham G, Milev R, Lawson JS: T3 augmentation of SSRI resistant depression. J Affect Disord 2006;91:211–215.
39.
Hudsin JI, Hiripi E, Pope HG Jr, Kessler RC: The prevalence and correlates of eating disorders in the national comorbidity survey replication. Biol Psychiatr 2007;61:348–358.
40.
Godart NT, Perdereau F, Rein Z, Berthoz S, Wallier J, Jeammet P, Flament MF: Comorbidity studies of eating disorders and mood disorders. Critical review of the literature. J Affect Disord 2007;97:37–49.
41.
Hulbert AJ: Thyroid hormones and their effects: a new perspective. Biol Rev 2000;75:519–631.
42.
Brambilla F, Santonastaso P, Caragero L, Favaro A: Disorders of eating behaviour: correlation between hypothalamo-pituitary-thyroid function and psychopathological aspects. Psychoneuroendocrinology 2006;31:131–136.
43.
Misra M, Klibanski A: Anorexia nervosa and osteoporosis. Rev Endocrinol Metab Disord 2006;7:91–99.
44.
Ohwada R, Hotta M, Oikawa S, Takano K: Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord 2006;39:598–601.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.